Viewing Study NCT04809233


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2025-12-26 @ 1:40 AM
Study NCT ID: NCT04809233
Status: AVAILABLE
Last Update Posted: 2025-06-04
First Post: 2021-03-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access to Tipifarnib
Sponsor: Kura Oncology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module